
Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older
JAMA Cardiology Author Interviews
00:00
Overview of IMPROVE-IT Trial
Richard G. Bach summarizes the IMPROVE-IT design, population, and primary result comparing ezetimibe plus simvastatin to simvastatin alone.
Play episode from 00:18
Transcript


